1 |
Gresham HD, et al. Survival of Staphylococcus aureus inside neutrophils contributes to infection. J Immunol. 2000;164:3713-22.
DOI
|
2 |
Maurin M, Raoult D. Use of aminoglycosides in treatment of infections due to intracellular bacteria. Antimicrob Agents Chemother. 2001; 45:2977-86.
DOI
ScienceOn
|
3 |
Navarre WW, Schneewind O. Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope. Microbiol Mol Biol Rev. 1999;63:174-229.
|
4 |
Dziewanowska K, et al. Fibronectin binding protein and host cell tyrosine kinase are required for internalisation of Staphylococcus aureus by epithelial cells. Infect Immunol. 1999;67:4673-8.
|
5 |
Janssen AM, Scheffer JJ, Baerheim SA. Antimicrobial activity of essential oils: a 1976-86 literature review. Aspects of the test methods. Planta Med. 1987; 53:395-8.
DOI
ScienceOn
|
6 |
Tenover FC, et al. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol. 1998;36:1020-7.
|
7 |
Cuffini AM, et al. Enhanced Staphylococcus aureus susceptibility to immuno-defense induced by sub-inhibitory and bactericidal concentration of imipenem. J Antimicrob Chemotherp. 1993;31:559-68.
DOI
ScienceOn
|
8 |
Almeida RA, et al. Staphylococcus aureus invasion of bovine mammary epithelial cells. J Dairy Sci. 1996;79 :1021-6.
DOI
ScienceOn
|
9 |
Menzies BE, Kourteva I. Internalisation of Staphylococcus aureus by endothelial cells induces apoptosis. Infect Immunol. 1998;66:5994-8.
|
10 |
정상설. 핵심유방학개론. 서울:고려의학. 1998:14-7.
|
11 |
신혁재. 유방염의 최신지견. 의약정보. 2011;37(1):22-7.
|
12 |
Jeon J, et al. Aqueous extract of the medicinal plant Patrinia villosaJuss. induces angiogenesis via activation of focal adhesion kinase. Microvasc Res. 2010;80:303-9.
DOI
ScienceOn
|
13 |
Xie Y, et al. Chemical composition and antioxidant activity of volatiles from Patrinia villosa Juss obtained by optimized supercritical fluid extraction. J Pharm Biomed Anal. 2008;48:796-801.
DOI
ScienceOn
|
14 |
Li N, et al. Studies on anti-inflammation chemical constitutes of Patrinia villosa. Zhong Yao Cai. 2008;31:51-3.
|
15 |
Department of Child and Adolescent Health and Development. Mastitis: causes and management. World Health Organization(Geneva):2000. Available from URL:http://libdoc.who.int/hq/2000 /WHO_FCH_CAH_00.13_spa.pdf.
|
16 |
Wambach KA. Lactation mastitis: a descriptive study of the experience. J Hum Lact. 2003;19:24-34.
DOI
|
17 |
Nordeng H, Tufte E, Nylander G. Treatment of mastitis in general practice. Tidsskr Nor Laegeforen. 2003;123(21):3027-30.
|
18 |
Spencer JP. Management of mastitis in breastfeeding women. Am Fam Physician. 2008;78:727-31.
|
19 |
Cassat J, et al. Transcriptional profiling of a Staphylococcus aureus clinical isolate and its isogenic agr and sarA mutants reveals global differences in comparison to the laboratory strain RN6390. Microbio. 2006;152:3075-90.
DOI
ScienceOn
|
20 |
Kevin P, Jaime F. Community-acquired methicillin-resistant Staphylococcus aureus:a growing public health problem. Pediatric Health. 2007;1(1):95-105.
DOI
|
21 |
Deresinski S. Methicillin-resistant staphylococcus aureus: an evolutionary epidemiologic and therapeutic odyssey. Clin Infect Dis. 2005;40(4):562-73.
DOI
ScienceOn
|
22 |
최성화 등. 부산 지역 설사 환자에서 분리한 MRSA 균주의 다양성 분석. J of Life Sci. 2008;18(8):1083-9.
DOI
ScienceOn
|
23 |
김세령, 원지혜, 김미라. 地楡 에탄올 추출물의 식품 위해성 세균에 대한 항균 활성 및 Salmonella serotype Typhimurium TA100에 대한 항돌연변이 활성 효과. 한국식품조리과학회지. 2011;27(4):17-26.
|
24 |
Kimura M, Yamada H. Interaction in the antibacterial activity of flavonoids from Sophora japonica L. to Propionibacterium. Yakugaku Zasshi. 1984;104:340-6.
DOI
|
25 |
Cha JD, et al. Antibacterial activity of sophoraflavanone G isolated from the roots of Sophora flavescens against methicillin-resistant Staphylococcus aureus. Phytother Res. 2009;23:1326-31.
DOI
ScienceOn
|
26 |
Garcia I, et al. Uptake and intracellularactivity of ofloxacin isomers in human phagocytic and nonphagocytic cells. Int J Antimicrob Agents. 2000;15:201-5.
DOI
ScienceOn
|
27 |
K Drlica K, Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev. 1997;61(3) :377-92.
|
28 |
송병기. 한방부인과학. 서울:행림출판. 1992:273-4.
|
29 |
대한병리학회. 병리학. 서울:고문사. 1990:1054-5.
|
30 |
Fass RJ. Ciprofloxacin: Best use of this new broad-spectrum antibiotic. Postgrad Med. 1990;87(8):117-31.
|
31 |
Pispirigos K, Chrysanthopoulos K. Evaluation of cardiac subacute toxicity of Ciprofloxacin in rats using serum biochemical parameters. Arzneimittelforshung. 2001;51:582-7.
|
32 |
Pons R, Escutia B. Ciprofloxacin-induced vasculitis with cutaneous and renal involvement. Nefrologia. 2001;21:209-12.
|
33 |
Egerbacher M, Edinger J, Tschulenk W. Effects of enrofloxacin and Ciprofloxacin hydrochloride on canine and equine chondrocytes in culture. Am J Vet Res. 2001;62:704-8.
DOI
ScienceOn
|
34 |
Williams RJ II, et al. The effect of Ciprofloxacin on tendon, paratenon, and capsular fibroblast metabolism. Am J Sports Med. 2000;28:364-9.
DOI
|
35 |
김인락 등. 本草學. 서울:永林社. 2007: 186-8, 205-56, 389-92, 434-47, 467-9, 478-89, 576-8, 583-5, 629-31.
|
36 |
김동현 등. 한방약리학. 서울:신일상사. 2006:223-5, 331-4, 369-70, 409-13.
|
37 |
Youn HJ, et al. Anti-protozoal efficacy of medicinal herb extracts against Toxoplasma gondii and Neospora caninum. Vet Parasitol. 2003;116:7-14.
DOI
ScienceOn
|
38 |
성인화. 白頭翁에서 분리한 Linoleic acid 와 시약용 Linoleic acid의 Methicillin -Resistant Staphylococcus aureus와 Candida albicans에 대한 항균효과 비 .교. 대한화학요법회지. 2002;20:295-302.
|
39 |
Seral C, Van Bambeke F, Tulkens PM. Quantitative analysis of gentamicin, azithromycin, telithromycin, Ciprofloxacin, moxifloxacin and oritavancin(LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages. Antimicrob Agents Chemother. 2003; 47:2283-92.
DOI
ScienceOn
|
40 |
Appelbaum PC, Hunter PA. The fluoroquinolone antibacterials: past, present and future perspectives. Int J Antimicrob Agents. 2000;16:5-15.
DOI
ScienceOn
|
41 |
Ackermann G, et al. Resistant to moxifloxacin in toxigenic Clostridium difficile isolates is associated with mutationsin gyrA. Antimicrob Agents Chemother. 2001;45:2348-53.
DOI
ScienceOn
|
42 |
Akasaka T, et al. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosaisolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance. Antimicrob Agents Chemother. 2001;45:2263-8.
DOI
ScienceOn
|
43 |
Bachoual R, et al. Single or double mutation alterations of gyrA associated with fluoroquinolone resistance in Carmpylobacter jejuni and Campylobacter coli. Microb Drug Resist. 2001;7:257-61.
DOI
ScienceOn
|
44 |
배종국. 한방유방학. 서울:정담. 2005 :153-81.
|
45 |
한방여성의학 편찬위원회. 한방여성의학 II. 서울:정담. 2007:446-9.
|
46 |
許浚. 東醫寶鑑. 경남:동의보감출판사. 2006:681-3.
|
47 |
Pfaller MA, et al. Collaborative investigation of variables in susceptibility testing of yeasts. Antimicrob Agents Chemother. 1990;34:1648-54.
DOI
ScienceOn
|